Clinical implications of atypical glandular cells of undetermined significance, favor endometrial origin

Cancer (Impact Factor: 4.89). 12/2001; 93(6):351 - 356. DOI: 10.1002/cncr.10139

The Bethesda System recommends qualifying atypical glandular cells with regard to their possible origin: endocervical versus endometrial. This study was undertaken to determine the clinical significance of atypical glandular cells of undetermined significance that favor an endometrial origin (AGUS-EM).METHODSA computer search identified 62 cervicovaginal smears (5.25% of all smears classified as AGUS) with a diagnosis of AGUS-EM in the files of Shared Cytopathology Laboratory of New York University Medical Center/Bellevue Hospital Medical Center between January 1995 and December 1999. The patients ranged in age from 29 years to 88 years (mean age, 53 years). Thirty-four patients were postmenopausal (55%), and 5 patients were on hormonal replacement therapy. Follow-up was available for 56 patients (90%); 45 patients (73%) underwent biopsy, and 11 patients (17%) had repeat cervicovaginal smears. Six patients were lost to follow-up.RESULTSAmong patients who underwent biopsy, 14 patients (31%) had a clinically significant uterine lesions, including 6 (13%) endometrial adenocarcinomas, 5 (11%) endometrial hyperplasias, and 3 (7%) squamous lesions (2 high-grade squamous intraepithelial lesions and 1 squamous cell carcinoma). Ten of 11 patients with significant endometrial pathology findings were postmenopausal. The remaining 31 patients had benign pathology results, which included chronic cervicitis, endometritis, endometrial polyps, microglandular hyperplasia, and tubal metaplasia. Among the patients with repeat cervicovaginal smears, one patient had atypical squamous cells of undetermined significance; the remaining patients were within normal limits.CONCLUSIONS
Approximately one-third of women with a diagnosis of AGUS-EM had a significant uterine lesion on subsequent biopsy; the majority of these lesions were endometrial in origin. Patients with a diagnosis of AGUS-EM on cervicovaginal smears should be followed closely, and endometrial curettage or biopsy should be included in their initial work-up. Cancer (Cancer Cytopathol) 2001;93:351–6. © 2001 American Cancer Society.

Download full-text


Available from: Paul A Elgert, Oct 16, 2014
76 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the frequency of detecting tubal metaplasia of the endocervix (TME) in cervico-vaginal cytological smears, we retrospectively reviewed 450 out of 2,371 cervico-vaginal Pap smears, selected by chance, with no glandular abnormality at the first examination (150 from women using intrauterine contraceptive device (IUD), 150 from sterilized women by bilateral tubal ligation (BTL); and 150 from women using no or other contraceptive methods). TME was seen in 16.7% of the patients using IUD; 70.1% of the patients submitted to BTL; and 49.0% of the patients from the last group. Atypical glandular cells on cervical cytology are a problem for clinicians and pathologists alike. The differential diagnosis of endocervical glandular abnormalities including TME is discussed.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abnormal uterine bleeding occurs across the entire age spectrum. Pregnancy, infection, birth-control methods, psychogenic causes, organic pathology, endocrine disorders, blood dyscrasias, systemic diseases and dysfunctional uterine bleeding are considered in the differential diagnosis. While the historical questions are similar regardless of age, the diagnostic methods, differential diagnosis and the management plan vary within each age bracket. Pregnancy-related disorders, infection, birth-control methods and psychogenic factors are the most common etiologies in younger women, but endocrine, systemic and hematologic disorders must be considered. In the middle years, irregular bleeding frequently occurs due to perimenopausal ovarian failure. With postmenopausal bleeding, endometrial carcinoma must always be ruled out. Treatment consists of correcting the underlying disorder. If no organic cause is identified, hormonal therapy or more invasive procedures are used.
    The Nurse Practitioner 05/1989; 14(4):40, 43-4, 47 passim.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The 2001 Bethesda System has radically altered the classification of glandular abnormalities. The recognition of the cytologic features of atypical glandular cells on cervicovaginal smears is important because a significant number of patients will be found to have an underlying cancerous or dysplastic lesion of the exocervix, endocervix, or endometrium. The differential diagnosis of AGC on cytology is diverse and accurate classification is necessary because the most appropriate form of follow-up depends on the specific subcategorization of the atypical glandular cells. Because the level of interobserver agreement in the diagnosis of AGC is poor, effective communication between cytopathologists and clinicians is essential to accurately triage these patients. This article should help the cytology practitioner by providing a comprehensive review of the approach to the interpretation, clinical significance, histopathologic correlation, and management of patients who have atypical glandular cells on gynecologic cytology specimens.
    Clinics in Laboratory Medicine 10/2003; 23(3):633-57. DOI:10.1016/S0272-2712(03)00057-X · 1.37 Impact Factor
Show more